Skip to content
Open access

Clinical Course and Outcomes of Complicated Community-Acquired Pneumonia in Children During a 5-Year Period Including the COVID-19 Pandemic

Sep 2026 · Turkish archives of pediatrics · 0 citations · 43 references

TL;DR

The findings are consistent with the fact that vaccine breakthrough infections, including those caused by pneumococcal serotypes 3 and 14, may still contribute to severe cCAP, whereas group A Streptococcus was identified in a minority of culture-positive cases.

Abstract

Objective: Community-acquired pneumonia (CAP) remains a significant cause of morbidity in children. Despite widespread vaccination, the incidence and clinical course of complicated CAP (cCAP) continue to pose diagnostic and therapeutic challenges. This study aimed to evaluate the clinical course, management, and outcomes of children with cCAP in pediatric clinical practice. Methods: This retrospective–prospective observational study was conducted at a tertiary university hospital between December 2019 and December 2024. Children under 18 years of age diagnosed with cCAP were included. Results: A total of 52 children were included, with a median age of 70.5 months; 48.1% were female. Parapneumonic effusion (PPE) was the most common complication (86.5%), followed by empyema (21.2%) and necrotizing pneumonia (7.6%). Bacterial pathogens were identified in a minority of cases. Among the limited number of culture-positive cases, group A Streptococcus and Streptococcus pneumoniae were the most frequently identified organisms (11.5%, n = 6). Chest tube thoracostomy was required in 60% of patients, and surgical intervention in 9.6%. Patients requiring chest tube placement had significantly higher C-reactive protein (CRP) levels and longer durations of intravenous (IV) antibiotic therapy. No mortality was observed. Conclusions: Despite extensive vaccination in healthy children, cases of cCAP still occur, and the causative agent is isolated only in a very few cases. The findings are consistent with the fact that vaccine breakthrough infections, including those caused by pneumococcal serotypes 3 and 14, may still contribute to severe cCAP, whereas group A Streptococcus was identified in a minority of culture-positive cases. Elevated CRP levels at admission may serve as a useful predictor for invasive interventions.

Read PDF

Similar papers

Open access Sep 2026

Clinical and Laboratory Profile of Mycoplasma pneumoniae Pneumonia among Children Aged 1 Month to 18 Years for 2 Years Admitted in a Tertiary Care Center: A Retrospective Study

To determine proportional morbidity among the children admitted with pneumonia and study clinical, laboratory, radiological findings, management of MP pneumonia (MPP), among hospitalized community-acquired pneumonia (CAP) cases in a tertiary care setting.

Sri Sounderya Yuvaraja Krishnan, Aishwarya Chidhambaram, N. Gowrishankar et al. · 0 citations
Open access Aug 2026

Trends and outcomes of Mycoplasma pneumoniae pneumonia in hospitalized children before, during, and after the coronavirus disease 2019 pandemic: a retrospective study in Northeast China, 2018–2023

ABSTRACT Mycoplasma pneumoniae pneumonia (MPP) is the most common form of community-acquired pneumonia, which shows an epidemic interval of 3–7 years. This study was conducted to understand the changing trends in MPP in children hospitalized before and during the coronavirus disease 2019 pandemic and determine adverse...

Chunxue Jiang, Xin Chen, Xuewen Xu et al. · 0 citations
Open access Sep 2026

Clinical and etiological characteristics of severe community-acquired pneumonia: A two-center retrospective analysis from Xi’an and Jiaxing in China

Severe community-acquired pneumonia, which is most often caused by K. pneumoniae in the authors' region, regularly complicates chronic obstructive pulmonary disease and other chronic pulmonary diseases, requires broad-spectrum antibiotics and life-support, and is associated with a relatively high mortality rate.

Xiao-Ni Ma, Lin Zhong, Ting Wang et al. · 0 citations

Clinical and Laboratory Predictors of Disease Severity in Hospitalized Children with COVID-19: A Study from the Early Pandemic Period

The aim of this manuscript is to evaluate the clinical, laboratory, and radiological characteristics of hospitalized children with COVID-19 and to compare findings according to disease severity, to understand risk factors associated with severe disease, particularly in upper-middle-income healthcare settings.

A. Boğa, Elif Betül, Keskin Çetinkaya et al. · 0 citations
Review Open access Sep 2026

Clinical presentation, laboratory profile and immediate outcome of   covid-19 patients in pediatric age group in a tertiary care centre- a retrospective observational study.

Background SARS‑CoV‑2 infection presentation in children is usually milder than in adults but can be severe and fatal as well particularly in association with certain comorbidities. Aims and objectives To Study Demographic Profile of Children Affected by Covid 19. To Study Clinical Presentation and Laboratory Profile...

Nitish Jena, Chandra Sekhar Patra, S. Mishra et al. · 0 citations
Open access Sep 2026

Etiological and clinical characteristics of severe pediatric pneumonia: a large retrospective tNGS cohort study using bronchoalveolar lavage fluid in Shandong, China

Severe pneumonia is the leading infectious cause of death among children under five years of age. Targeted next-generation sequencing (tNGS), a rapid and cost-effective tool for comprehensive pathogen detection, is increasingly used in clinical settings. A retrospective study was conducted among children...

Shu-Yun Wang, Xin Lv, Yu Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.